跳到正文
原文
NEJM 新英格兰医学杂志· Liesbeth Van WesenbeeckFreya RasschaertJohnson & Johnson, Beerse, BelgiumKristen K. PierceUniversity of Vermont College of Medicine, BurlingtonGuillermo Herrera-TaracenaJohnson & Johnson, Horsham, PABeulah P. SabundayoJohns Hopkins Bloomberg School of Public Health, BaltimoreAnnemie BuelensJohnson & Johnson, Beerse, BelgiumPatricia LuttonUniversity of Vermont College of Medicine, BurlingtonVeerle Van EygenJohnson & Johnson, Beerse, BelgiumMegan McKnightJohns Hopkins Bloomberg School of Public Health, BaltimoreKim De ClerckJohnson & Johnson, Beerse, BelgiumIsabel FetterUniversity of Vermont College of Medicine, BurlingtonXi FangJohns Hopkins Bloomberg School of Public Health, BaltimoreNele GoeyvaertsKathleen CallewaertJohnson & Johnson, Beerse, BelgiumSarah SampsonJeffrey MayfieldJohns Hopkins Bloomberg School of Public Health, BaltimoreOliver LenzSandra De MeyerJohnson & Johnson, Beerse, BelgiumThomas N. KakudaJohnson & Johnson, San Diego, CAHelen HeJohns Hopkins Bloomberg School of Public Health, BaltimoreEmérito Amaro-CarambotNational Institute of Allergy and Infectious Diseases, Bethesda, MDRuxandra Draghia-AkliJohnson & Johnson, Spring House, PAMarya CarmolliUniversity of Vermont College of Medicine, BurlingtonMarnix Van LoockJohnson & Johnson, Beerse, BelgiumStephen S. WhiteheadNational Institute of Allergy and Infectious Diseases, Bethesda, MDAnna P. DurbinJohns Hopkins Bloomberg School of Public Health, Baltimore·· 2026-10-14精选AI 评分62

每周一次 Mosnodenvir 作为登革热预防在人体感染模型中的效果

Once-Weekly Mosnodenvir as Dengue Prophylaxis in a Human Infection Model

AI 导读

研究发现,每周一次 Mosnodenvir 可有效预防登革热感染,为登革热的预防提供了新的药物选择。

推荐理由

研究显示某药在预防登革热感染中的效果,为登革热防治提供新思路。

来源:NEJM 新英格兰医学杂志 · nejm.org